참고문헌
- Biederer, C., Ries, S., Brandts, C.H., and Mccormick, F. (2002). Replication-selective viruses for cancer therapy. J. Mol. Med. 80, 163-175 https://doi.org/10.1007/s00109-001-0295-1
- Clayman, G.L., El-naggar, A.K., Lippman, S.M., Henderson, Y.C., Frederick, M., Merritt, J.A., Zumstein, L.A., Timmons, T.M., Liu, T.J., Ginsberg, L., et al. (1998). Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16, 2221-2232 https://doi.org/10.1200/JCO.1998.16.6.2221
- Crystal, R.G., Mcelvaney, N.G., Rosenfeld, M.A., Chu, C.S., Mastrngeli, A., Hay, J.G., Brody, S.L., Jaffe, H.A., Eissa, N.T., and Danel, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42-51 https://doi.org/10.1038/ng0994-42
- Fallaux, F.J., Bout, A., Van der Velde, I., Van den Wollenberg, D.J., Hehir, K.M., Keegan, J., Auger, C., Cramer, S.J., Van Ormondt, H., Van der EB, A.J., et al. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-com-petent adenoviruses. Hum. Gene Ther. 9, 1909-1917 https://doi.org/10.1089/hum.1998.9.13-1909
- Freytag, S.O., Stricker, H., Pegg, J., Paielli, D., Pradhan, D.G., Peabody, J., Deperalta-Venturian, M., Xia, X., Brown, S., Lu, M., et al. (2003). Phase I study of replication-competent adenovirus- mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res. 63, 7497-7506
- Ganly, I., Kirn, D., Eckhardt, G., Rodriguez, G.I., Soutar, D.S., Otto, R., Robertson, A.G., Park, O., Gulley, M.L., Heise, C., et al. (2000). A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin. Cancer Res. 6, 798-806
- Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74 https://doi.org/10.1099/0022-1317-36-1-59
- Hamada, K., Desaki, J., Nakagawa, K., Zhang, T., Shirakawa, T., Gotoh, A., and Tagawa, M. (2007). Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy. Mol. Ther. 15, 1121-1128 https://doi.org/10.1038/sj.mt.6300128
- Huebner, R.J., Rowe, W.P., Schatten, W.E., Smith, R.R., and Thomas, L.B. (1956). Studies on the use of viruses in the treatment of carcinoma of the cervix. Cancer 9, 1211-1218 https://doi.org/10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7
- Kreppel, F., and Kochanek, S. (2008). Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol. Ther. 16, 16-29 https://doi.org/10.1038/sj.mt.6300321
- Lonberg-Holm, K., and Philipson, L. (1969). Early events of virus-cell interaction in an adenovirus system. J. Virol. 4, 323-338
- Mettler, N.E., Clarke, D.H., and Casals, J. (1982). Virus inoculation in mice bearing Ehrlich ascitic tumors: antigen production and tumor regression. Infect. Immun. 37, 23-27
- Mizuguchi, H., and Hayakawa, T. (2004). Targeted adenovirus vectors. Hum. Gene Ther. 15, 1034-1044 https://doi.org/10.1089/hum.2004.15.1034
- Nemunaitis, J., Swisher, S.G., Timmons, T., Connors, D., Mack, M., Doerksen, L., Weill, D., Wait, J., Lawrence, D.D., Kemp, B.L., et al. (2000). Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J. Clin. Oncol. 18, 609-622 https://doi.org/10.1200/JCO.2000.18.3.609
- Peng, Z. (2005). Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther. 16, 1016-1027 https://doi.org/10.1089/hum.2005.16.1016
- Power, A.T., and Bell, J.C. (2007). Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer. Mol. Ther. 15, 660-665 https://doi.org/10.1038/sj.mt.6300098
- Raper, S.E., Chirmule, N., Lee, F.S., Wivel, N.A., Bagg, A., Gao, G.P., Wilson, J.M., and Batshaw, M.L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148-158 https://doi.org/10.1016/j.ymgme.2003.08.016
- Rowe, W.P., Huebner, R.J., Gilmore, L.K., Parrott, R.H., and Ward, T.G. (1953). Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 84, 570-573
- Russell, W.C. (2000). Update on adenovirus and its vectors. J. Gen. Virol. 81, 2573-2604 https://doi.org/10.1099/0022-1317-81-11-2573
- Sakhuja, K., Reddy, P.S., Ganesh, S., Cantaniag, F., Pattison, S., Limbach, P., Kayda, D.B., Kadan, M.J., Kaleko, M., and Connelly, S. (2003). Optimization of the generation and propagation of gutless adenoviral vectors. Hum. Gene Ther. 14, 243-254 https://doi.org/10.1089/10430340360535797
- Saukkonen, K., and Hemminki, A. (2004). Tissue-specific promoters for cancer gene therapy. Expert Opin. Biol. Ther. 4, 683-696 https://doi.org/10.1517/14712598.4.5.683
- Shirakawa, T., Terao, S., Hinata, N., Tanaka, K., Takenaka, A., Hara, I., Sugimura, K., Matsuo, M., Hamada, K., Fuji, K., et al. (2007). Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. Hum. Gene Ther. 18, 1225-1232 https://doi.org/10.1089/hum.2007.074
- Southam, C.M., and Moore, A.E. (1952). Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus. Cancer 5, 1025-1034 https://doi.org/10.1002/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q
- Southam, C.M., Hilleman, M.R., and Werner, J.H. (1956). Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. J. Lab Clin. Med. 47, 573-582
- Vaha-Koskela, M.J., Heikkila, J.E., and Hinkkanen, A.E. (2007). Oncolytic viruses in cancer therapy. Cancer Lett. 254, 178-216 https://doi.org/10.1016/j.canlet.2007.02.002
- Vattemi, E., and Claudio, P.P. (2006). Adenoviral gene therapy in head and neck cancer. Drug News Perspect. 19, 329-337 https://doi.org/10.1358/dnp.2006.19.6.1015352
- Volpers, C., and Kochanek, S. (2004). Adenoviral vectors for gene transfer and therapy. J. Gene Med. 6 (Suppl. 1), S164-171 https://doi.org/10.1002/jgm.496
- Yu, W., and Fang, H. (2007). Clinical trials with oncolytic adenovirus in China. Curr. Cancer Drug Targets 7, 141-148 https://doi.org/10.2174/156800907780058817
- Zeimet, A.G., and Marth, C. (2003). Why did p53 gene therapy fail in ovarian cancer? Lancet Oncol. 4, 415-422 https://doi.org/10.1016/S1470-2045(03)01139-2